Cargando…
Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy
Acute myeloid leukemia (AML) is an aggressive group of cancers with high mortality rates and significant relapse risks. Current treatments are insufficient, and new therapies are needed. Recent discoveries suggest that AML may be particularly sensitive to chemotherapeutics that target mitochondria....
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146088/ https://www.ncbi.nlm.nih.gov/pubmed/32318340 http://dx.doi.org/10.3389/fonc.2020.00435 |